As of March 31, 2026, HRS Aluglaze Ltd. carries a market capitalization of 5.13B, placing it among publicly traded companies globally. Its enterprise value stands at 5.45B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 5.13B |
| Enterprise Value | 5.45B |
As of March 31, 2026, HRS Aluglaze Ltd. has 19.28M shares outstanding.
| Shares Outstanding | 19.28M |
These figures are as of March 31, 2026.
| PB Ratio | 6.80 |
| P/TBV Ratio | 6.83 |
As of March 31, 2026, HRS Aluglaze Ltd. maintains a current ratio of 1.83, meaning it holds 1.8x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 1.83 |
| Quick Ratio | 0.22 |
| Debt / Equity | 52.25 |
These figures are as of the close on October 22, 2026. The 50-day moving average sits at 255.14, while the 200-day moving average is 236.63.
| 50-Day Moving Average | 255.14 |
| 200-Day Moving Average | 236.63 |
As of March 31, 2026, HRS Aluglaze Ltd. holds 76.38M in cash and equivalents against 394.25M in total debt, resulting in a net debt position of 392.87M. Total book value stands at 754.18M, with working capital of 292.90M providing operational flexibility.
| Cash & Cash Equivalents | 76.38M |
| Total Debt | 394.25M |
| Net Debt | 392.87M |
| Equity (Book Value) | 754.18M |
| Book Value Per Share | 39.11 |
| Working Capital | 292.90M |
Already premium?